BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12808036)

  • 1. Ca2+-dependent binding and activation of dormant ezrin by dimeric S100P.
    Koltzscher M; Neumann C; König S; Gerke V
    Mol Biol Cell; 2003 Jun; 14(6):2372-84. PubMed ID: 12808036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of a novel, permanently active S100P mutant.
    Austermann J; Nazmi AR; Heil A; Fritz G; Kolinski M; Filipek S; Gerke V
    Biochim Biophys Acta; 2009 Jun; 1793(6):1078-85. PubMed ID: 19111582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezrin interacts with the scaffold protein IQGAP1 and affects its cortical localization.
    Nammalwar RC; Heil A; Gerke V
    Biochim Biophys Acta; 2015 Sep; 1853(9):2086-94. PubMed ID: 25554515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration.
    Austermann J; Nazmi AR; Müller-Tidow C; Gerke V
    J Biol Chem; 2008 Oct; 283(43):29331-40. PubMed ID: 18725408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomerization and divalent ion binding properties of the S100P protein: a Ca2+/Mg2+-switch model.
    Gribenko AV; Makhatadze GI
    J Mol Biol; 1998 Oct; 283(3):679-94. PubMed ID: 9784376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100P is a novel interaction partner and regulator of IQGAP1.
    Heil A; Nazmi AR; Koltzscher M; Poeter M; Austermann J; Assard N; Baudier J; Kaibuchi K; Gerke V
    J Biol Chem; 2011 Mar; 286(9):7227-38. PubMed ID: 21177863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hydrophobic amino acid residues involved in the formation of S100P homodimers in vivo.
    Koltzscher M; Gerke V
    Biochemistry; 2000 Aug; 39(31):9533-9. PubMed ID: 10924150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of the occurrence of endometrioid carcinoma by S100 calcium binding protein P.
    Zhang D; Chen X; Xia H; Wang L; Zhao H; Xu B; Zhang A; Zhang W
    BMC Cancer; 2020 Sep; 20(1):845. PubMed ID: 32883230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site.
    Gary R; Bretscher A
    Mol Biol Cell; 1995 Aug; 6(8):1061-75. PubMed ID: 7579708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100P, a novel Ca(2+)-binding protein from human placenta. cDNA cloning, recombinant protein expression and Ca2+ binding properties.
    Becker T; Gerke V; Kube E; Weber K
    Eur J Biochem; 1992 Jul; 207(2):541-7. PubMed ID: 1633809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.
    Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M
    J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monomeric state of S100P protein: Experimental and molecular dynamics study.
    Permyakov SE; Denesyuk AI; Denessiouk KA; Permyakova ME; Kazakov AS; Ismailov RG; Rastrygina VA; Sokolov AS; Permyakov EA
    Cell Calcium; 2019 Jun; 80():152-159. PubMed ID: 31103949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect association of ezrin with F-actin: isoform specificity and calcium sensitivity.
    Shuster CB; Herman IM
    J Cell Biol; 1995 Mar; 128(5):837-48. PubMed ID: 7876308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational and thermodynamic properties of peptide binding to the human S100P protein.
    Gribenko AV; Guzmán-Casado M; Lopez MM; Makhatadze GI
    Protein Sci; 2002 Jun; 11(6):1367-75. PubMed ID: 12021435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-dependent interaction of monomeric S100P protein with serum albumin.
    Kazakov AS; Shevelyova MP; Ismailov RG; Permyakova ME; Litus EA; Permyakov EA; Permyakov SE
    Int J Biol Macromol; 2018 Mar; 108():143-148. PubMed ID: 29175526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezrin mutants affecting dimerization and activation.
    Chambers DN; Bretscher A
    Biochemistry; 2005 Mar; 44(10):3926-32. PubMed ID: 15751968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation and functional implication of S100P in cancer.
    Gibadulinova A; Tothova V; Pastorek J; Pastorekova S
    Amino Acids; 2011 Oct; 41(4):885-92. PubMed ID: 20155429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly specific interaction of monomeric S100P protein with interferon beta.
    Kazakov AS; Mayorov SA; Deryusheva EI; Avkhacheva NV; Denessiouk KA; Denesyuk AI; Rastrygina VA; Permyakov EA; Permyakov SE
    Int J Biol Macromol; 2020 Jan; 143():633-639. PubMed ID: 31821828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of F-actin binding capacity of ezrin: synergism of PIP₂ interaction and phosphorylation.
    Bosk S; Braunger JA; Gerke V; Steinem C
    Biophys J; 2011 Apr; 100(7):1708-17. PubMed ID: 21463584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin binding of ezrin is activated by specific recognition of PIP2-functionalized lipid bilayers.
    Janke M; Herrig A; Austermann J; Gerke V; Steinem C; Janshoff A
    Biochemistry; 2008 Mar; 47(12):3762-9. PubMed ID: 18302339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.